For more information, visit http://theconferenceforum.org/conferences/disruptive-innovations-us/overview/.
Jeff Lee, CEO, will be moderating a panel at the 4th Annual Mobile in Clinical Trials Summit in Boston. We will post more details as they become available.
Panel: Stop Window Shopping: How to Overcome the Cultural Barrier to Mobile Implementation
Moderator: Jeff Lee, CEO, mProve Health
For more information, visit http://theconferenceforum.org/conferences/mobile-in-clinical-trials/overview/.
Denis Curtin, CSO, mProve Health, will be co-presenting with Takeda on “The Development and Launch of a Unique Retention Focused Patient Centric Online Community for the TOMMORROW Study.”
To improve the experience of Alzheimer’s Disease patients in their clinical trial, the TOMMORROW study team created an innovative, technology-focused online community. Online gathering places can easily incorporate fundamental features of community such as membership, a sense of influence, and shared emotional connection. However, some of these features can be difficult to incorporate into a necessarily confidential and highly controlled clinical trial. The TOMMORROW study community addresses these challenges in several innovative ways. It safely incorporates the benefits of community building into a clinical trial, thus supporting patient engagement and positive outcomes.
For more details, visit http://www.diaglobal.org/en/flagship/dia-2017